International Journal of the Economics of Business

A Special Commemorative Issue Honoring William S. Comanor and 50 Years of Pharmaceutical Economics
pp. 165-168(4)
Author: Hay, Joel W.

Pharmaceutical Economics Since the 1960s: Plus Ça Change, Plus C’est La Même Chose
pp. 169-171(3)
Author: Comanor, William S.

Do “Reverse Payment” Settlements Constitute an Anticompetitive Pay-for-Delay?
pp. 173-200(28)
Authors: Drake, Keith M.; Starr, Martha A.; McGuire, Thomas G.

Newton’s First Law as Applied to Pharmacies: Why Entry Order Matters for Generics
pp. 201-217(17)
Authors: Shajarizadeh, Ali; Grootendorst, Paul; Hollis, Aidan

A Ban on “Private Label” Generic Pharmaceuticals: Legal and Economic Context
pp. 219-229(11)
Authors: Anis, Aslam H.; Harvard, Stephanie

Similar Products at Different Prices: Can Biopharmaceutical Companies Segment Markets?
pp. 231-243(13)
Authors: Manning, Richard; Stomberg, Christopher; Scher, Benjamin; Twigg, Kathleen; Huson, Andrew

Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive?
pp. 245-261(17)
Author: Danzon, Patricia M.

European Union Pharmaceutical Markets: A Case for Differential Pricing?
pp. 263-275(13)
Authors: Towse, Adrian; Pistollato, Michele; Mestre-Ferrandiz, Jorge; Khan, Zeba; Kaura, Satyin; Garrison, Louis

Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995–2010
pp. 277-299(23)
Author: Lichtenberg, Frank R.

The Nature of Pharmaceutical Competition: Implications for Antitrust Analysis
pp. 301-343(43)
Authors: Frank, Richard G.; Hartman, Raymond S.